Placeholder Banner

BIO Letter to Senate on Key Priorities for Fiscal Year 2023 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act

May 4, 2022

BIO supports public policies centered on innovation to incentivize the adoption of cutting-edge technologies and practices to maintain America’s leadership and benefit our rural economies. Further, it is crucial that the government establish risk-proportionate, transparent regulations in a timely manner that spur biological innovations and biobased technologies while protecting health and the environment.

As such, BIO urges the committee to actively support the following priorities as it develops the Fiscal Year 2023 (FY 2023) Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act:

Download Full Comments Below
FY23 BIO Senate AgFDA Request Letter
Discover More
On behalf of the U.S. Biostimulant Coalition (USBC), the Biological Products Industry Alliance (BPIA), the American Seed Trade Association (ASTA), the Biotechnology Innovation Organization (BIO), and the Humic Products Trade Association, we are…
The Biotechnology Innovation Organization (BIO) is the largest biotechnology trade association, representing approximately 1,000 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United…
The value of science and agricultural innovation cannot be understated. The adoption of biotechnology in agriculture and the development of biobased technologies contribute to food security, sustainability, and climate change solutions. Over the…